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Maslinic acid (MA) is a natural compound whose structure corresponds to a pentacyclic triterpene. It is abundant in the cuticular
lipid layer of olives. MA has many biological and therapeutic properties related to health, including antitumor, anti-inflammatory,
antimicrobial, antiparasitic, antihypertensive, and antioxidant activities. However, no studies have been performed to understand
the molecular mechanism induced by this compound in melanoma cancer. The objective of this study was to examine the
effect of MA in melanoma (B16F10) cells grown in the presence or absence of fetal bovine serum (FBS). We performed cell
proliferation measurements, and the reactive oxygen species (ROS) measurements using dihydrorhodamine 123 (DHR 123) and
activities of catalase, glucose 6-phosphate dehydrogenase, glutathione S-transferase, and superoxide dismutase.These changes were
corroborated by expression assays. FBS absence reduced cell viability decreasing IC
50
values of MA. The DHR 123 data showed an
increase in the ROS level in the absence of FBS. Furthermore, MA had an antioxidant effect at lower assayed levels measured as
DHR and antioxidant defense. However, at higher dosagesMA induced cellular damage by apoptosis as seen in the results obtained.
1. Introduction
Olea europaea L. is an evergreen tree widely distributed in
the Mediterranean countries, where they cover 8 million ha,
accounting for almost 98% of the world crop [1]. It is studied
for its alimentary use (the fruits and the oil are important
components in the daily diet of a large part of the world’s
population), whereas the leaves and seeds are important for
their secondary metabolites such as terpenes group.
Maslinic acid (MA), a natural pentacyclic triterpene, has
attracted much interest due to its proven pharmacologic
safety and its many biological activities, such as antiviral [2],
antidiabetogenic [3], anti-inflammatory [4], and antimicro-
bial [5] functions. More recently, some studies have shown
that MA has anticancer property in different types of cancer
[6–12]. Moreover, MA inhibits glycogen phosphorylase in rat
liver and muscle [13–15], decreases glucose in diabetogenic
mouse [16], and stimulates healthy whole animal and tissue
growth [17–21]. Although a recent study showed that MA
induces apoptosis in several cancer cells no such effect
has been reported in melanoma cells. In particular, the
involvement of MA-mediated reactive oxygen species (ROS)
production in apoptotic signaling in B16F10 melanoma cells
remains unknown. Oxidative stress refers to a cell’s state
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characterized by excessive production of ROS and is one of
the most important regulatory mechanisms for cancer [22].
To protect from high ROS levels, living organisms possess
an enzymatic antioxidant that scavenges them. In a normal
situation, ROS can be detrimental when produced in high
amounts in the intracellular compartments and cells gen-
erally respond to ROS by upregulating antioxidants such
as superoxide dismutase (SOD), catalase (CAT), glutathione
peroxidase (GPx), and glutathione S-transferase (GST) that
protect them by converting dangerous free radicals to
harmless molecules. Glucose-6-phosphate dehydrogenase
(G6PDH) is also involved in the antioxidant mechanism
as it produces NADPH which is a direct scavenger of free
radicals [23]. ROS and cellular oxidant stress have long been
associated with cancer processes [24, 25]. In cancer cells,
oxidative stress has been linked to the regulation of numer-
ous cellular processes including DNA damage, proliferation,
cellular adhesion, and migration and the regulation of cell
survival or death [26].
Previous studies have shown that ROS induce depolar-
ization of the mitochondrial-membrane potential as well as
release of cytochrome c from the mitochondria into the
cytosol. This increase triggers the activation of caspase-9
and initiates the caspase cascade, which induces apoptosis
in tumor cells [6, 7, 27]. Recently, many reports have shown
that components from plants such as celastrol [28, 29] and
jacaranone [30] induce apoptosis of melanoma cells through
production of ROS.
The aim of this study is to observe the effect of MA in
the absence of fetal bovine serum (FBS) in B16F10 melanoma
cells by analyzing the ROS production and the activity and
expression of themain antioxidants enzymes considering that
the absence of FBS during growth causes a clear situation of
cellular stress.
2. Materials and Methods
2.1. Drug. MA was kindly provided by Biomaslinic S.L. Its
molecular weight is 472.7 g/mol. Figure 1 shows the chemical
structure of MA ((2𝛼,3𝛽)-2,3-dihydroxyolean-12-en-28-oic
acid). The extract used is a chemically pure white powder
comprising 98% MA and is stable when stored at 4∘C. MA
was dissolved before use at 10mg/mL in 50% DMSO and
50% PBS. Stock solution was frozen and stored at −20∘C. For
treatments, this solution was diluted in cell culture medium.
2.2. Cell Line and Experimental Conditions. B16F10 cells
were cultured in high-glucose DMEM supplemented with
2mM glutamine, 10% heat-inactivated FBS, 10,000 units/mL
penicillin, and 10mg/mL streptomycin. The cell line was
maintained in a humidified atmosphere with 5%CO
2
at 37∘C.
Cells were passaged at preconfluent densities by the use of
a solution containing 0.05% trypsin and 0.5mM EDTA. The
B16F10 cells were seeded in the culture dishes at the desired
density. After 24 h hours, when the cells are attached to the
dish, the dishes were incubated with DMEM containing 0%
FBS or 10% FBS for 24 h under the conditions described for














Figure 1: The chemical structure of maslinic acid (MA).
2.3. Cell Proliferation. The assay was performed by a vari-
ation of the method described by Mosmann [31]. Samples
containing 200 𝜇L cell suspension (1.5 ⋅ 103 cells/well) were
cultured in 96-well plates. Subsequent to the adherence of the
cells within 24 h of incubation with and without FBS at 37∘C,
different MA dilutions on a scale of 10 𝜇g/mL to 100 𝜇g/mL
were added separately. Following incubation for 24 h at 37∘C
in a humidified incubator with 5% CO
2
, MTT dissolved in
PBS andmediumat 5mg/mL and sterile-filteredwas added to
all the wells at a final concentration of 0.5mg/mL. Following
2 h incubation, the generated formazan was dissolved with
100 𝜇L DMSO per well. The optical density was measured on
an ELISA plate reader (ELISA, ELx800, Bio-Tek) at 550 nm.
Absorbance was proportional to the number of cells. The




2.4. Protein Extraction. For sample preparation, cells at
70% confluence were incubated for 24 h without FBS and






concentrations for 24 h. Following this, the cells were washed
three times with PBS, scraped offwith a cell scraper (Renner),
and collected in 0.5mL RIPA buffer. Immediately, cells were
sonicated on ice for 5min and maintained by moderate
shaking at 4∘C for 1 h. Every 15min, the samples were
moderately shaken in a vortex. The lysates were spun in a
centrifuge at 10,000 g at 4∘C for 15min.The supernatants were
used for enzyme activity and Western blot assays, and the
protein concentrations were measured by BCA Protein Assay
(Thermo Scientific, USA). For each experimental group, 2
replicates of the homogenates were made. Each replicate was
made with 3 different cell populations.
2.5. Mitochondrial-Membrane Potential by DHR 123.
Changes in the mitochondrial-membrane potential can be
examined by monitoring the cell fluorescence after double
staining with rhodamine 123 (Rh123) and propidium iodide
(PI). Rh123 is a membrane-permeable fluorescent cationic
dye that is selectively taken up by mitochondria directly
proportional to theMMP (mitochondrial-membrane perme-
abilization). Around 4 × 105 cells/well were placed on 6-well
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concentrations. Following the treatment, the medium
was removed and a fresh medium with DHR, at a final
concentration of 5𝜇g/mL, was added. After 30min of
incubation, the medium was removed and the cells were
washed and resuspended in PBS with 5𝜇g/mL of PI. The
intensity of fluorescence from Rh123 and PI was determined
using an ACS flow cytometer (Coulter Corporation, Hialeah,
FL, USA), at the excitation and emission wavelengths of
500 nm and 536 nm, respectively.
2.6. Enzyme Assays. All enzyme assays were carried out at
25∘C using a PowerWave Xmicroplate scanning spectropho-
tometer (Bio-Tek Instruments, USA) and run in duplicate in
96-well microplates. This made it necessary to adapt all the
enzymatic methods described below to the microplate reader
to obtain optimal activities. Adaptation of the methods was
done by scaling down the reaction mixtures to a final volume
of 200𝜇L and by adjusting both the total time for which
reactions were allowed to proceed and the measurement
intervals. In addition, the optimal substrate and protein
concentrations for the measurement of maximal activity for
each enzyme were established by preliminary assays.
The enzymatic reactions were initiated by addition of the
tissue extract, except for SOD where xanthine oxidase was





NADH/NADPH, and DTNB [5,5-dithiobis (2-nitrobenzoic
acid)] were 0.039, 6.22, and 13.6, respectively. The assay
conditions were as follows.
Superoxide dismutase (SOD; EC 1.15.1.1) activity was
measured by the ferricytochrome c method using xan-
thine/xanthine oxidase as the source of superoxide radi-
cals. The reaction mixture consisted of 50mM potassium
phosphate buffer (pH 7.8), 0.1mM EDTA, 0.1mM xanthine,
0.013mM cytochrome c, and 0.024 IU/mL xanthine oxidase.
Activity is reported in units of SOD per milligram of protein.
One unit of activity was defined as the amount of enzyme
necessary to produce a 50% inhibition of the ferricytochrome
c reduction rate [32].
Catalase (CAT; EC 1.11.1.6) activity was determined by
measuring the decrease of hydrogen peroxide concentration
at 240 nm according to Aebi [33]. The reaction mixture
contained 50mm potassium phosphate buffer (pH 7.0) and





Glucose-6-phosphate dehydrogenase (G6PDH; EC
1.1.1.49) activity was determined at pH 7.6 in a medium
containing 50mM Hepes buffer, 2mM MgCl
2
, 0.8mM
NADP+ and glucose 6-phosphate were used as substrate.
The enzyme activity was determined by measuring the
reduction of NADP+ at 340 nm as previously described by
Lupiañez et al. [34] and Peragón et al. [35]. The change in
absorbance at 340 nm was recorded and, after confirmation
of no exogenous activity, the reaction started by the addition
of substrate.
Glutathione S-transferase (GST; EC 2.5.1.18) activity was
measured according to the method described by Habig et al.
[36], using 1-chloro-2,4-dinitrobenzene as a substrate.
2.7. Western Blot Analysis. Polyacrylamide gel electrophore-
sis under denaturing conditions (SDS-PAGE) was performed
in a Mini-Protean II electrophoresis system (Bio-Rad, Rich-
mond, USA). The cell extract were mixed with a charge
buffer that contained 62.5mM Tris-HCl at pH 6.8, 20 g L−1
SDS, 100mLL−1 glycerol, 25 g L−1 𝛽-mercaptoethanol and
0.045mM bromophenol blue and then heated for 5min
at 100∘C. Polypeptides were separated on a 12% SDS-
PAGE and subsequently transferred to polyvinylidene flu-
oride membranes with a semidry electroblotting system at
1.5mA/cm2 for 45min in a medium containing 25mM Tris-
HCl, 192mM glycine, 200mLL−1 methanol, and 1 g L−1 SDS.
Blots were blocked for 2 h at room temperature with a
Tris buffered solution (TBS) that contained 25mM Tris-
HCl, 100mMNaCl, 2.5mMKCl, pH 7.6, 1mL L−1 Tween
20, and 15 g L−1 bovine serum albumin (BSA) at pH 7.6.
Membranes were washed with TBS containing 1mLL−1
Tween 20 (TBS-T) for 15min and later incubatedwith specific
primary antibodies: anti-glucose 6-phosphate dehydrogenase
(G6PDH) 1 : 1,000 (Sigma, A9521), anti-SOD 1 : 500 (Santa
Cruz Biotechnology, sc-101523), anti-GST 1 : 1,000 (Santa
Cruz Biotechnology, sc-374171), anti-CAT 1 : 1,000 (Santa
Cruz Biotechnology, sc-34285), anti-G6PDH 1 : 5,000 (Sigma,
A9521), and anti-𝛼-actin 1 : 1,000 (Sigma, A2668). Following
three washes with TBS-T containing 10 g L−1 BSA (TBS-T-
BSA) for 10min, membranes were incubated with a HRP
conjugated goat anti-rabbit antibody IgG or anti-mouse IgG
(1 : 10,000). Blots were developed using the ECL-PlusWestern
blot detection system (GE Healthcare). The specific signals
were exposed on medical film (Konica Minolta). Films were
scanned with a Hewlett-Packard scanner and quantified
using Multi-Gauge program (Fuji Film Europe).
2.8. Statistical Analysis. Data are shown as mean ± the stan-
dard deviation (SD).The statistical significance of differential
findings between non-FBS group and control was determined
by Student’s 𝑡-test. One-way ANOVA test was performed
to determine the significance of the differences between
MA concentrations. SPSS version 15.0 for Windows software
packagewas used for statistical analysis.𝑃 values smaller than
0.05 were considered statistically significant.
3. Results and Discussion
3.1. FBS Deprivation and Cellular Growth. We examined the
effect of MA on the proliferation of B16F10 melanoma cell
lines using MTT assay under the presence and absence of
FBS. Several groups have studied the effects of the absence
of FBS in cancer cells. However, their focus has not been
on the variation of cytotoxicity of a compound but on the
synchronization of the cells in a particular phase of cell cycle
as it was reported that the deprivation of FBS allows arrest




cell cycle stage [37]. It has been
shown that lower concentrations of FBS (0.5% and 0.75%)
caused a significant decrease in cellular quantity and this
condition could induce DNA fragmentation and subsequent
cell death [38]. Moreover, several studies have been focused
on improving the composition of FBS in order to enhance
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Units (𝜇g/mL) (𝜇M) (𝜇g/mL) (𝜇M)
4.61 ± 0.08 10.78 ± 0.19 0.19 ± 0.01 0.44 ± 0.02
18.44 ± 0.94 43.11 ± 2.20 0.74 ± 0.01 1.73 ± 0.02 






Figure 2:The effect of MA on B16F10 murine melanoma cell viability in the presence of FBS (a) and in the absence of FBS (b). MA cytotoxic
doses are shown in (c). Cell proliferation was determined by MTT assay. Values are expressed as means ± SD.
the culture cell growth; in this sense, FBS dose dependent
studies have been performed [39].
Percentage of living cells (viable formazan accumulating
cells) decreased in a dose dependent manner in the presence
and absence of FBS. We noticed that 50% growth inhibition
values (IC
50
) in response to MA were different in media
without FBS, compared to media supplemented with FBS;
therefore, MA has an increased cytotoxic effect when cells do
not have FBS. These results are reported in Figure 2.
MAdose, which reaches IC
50
value in the culturemedium
supplemented with 10% of FBS, was 36.88 𝜇g/mL (86 𝜇M)
and 1.48 𝜇g/mL (3.5 𝜇M) in a medium with 0% of FBS.These
results indicate that MA has a cytotoxic effect with FBS in
the cell culture, but this effect is higher in its absence. Our
explanation of this is that absence of FBS modifies the cell
homeostasis causing an increase of free radicals and therefore,
MA presents a higher cytotoxic effect in the absence of
FBS. An imbalance between free radicals and antioxidants
results in a condition known as oxidative stress, which
leads to metabolic malfunctions and damage to biological
macromolecules [40].
MA cytotoxicity has been studied by other groups in
several types of cancer cells and it has been shown that the
MA quantity has a variable effect on the function of the type
of cells and experimental conditions. For example, in HT29
cells theMA quantity that results in growth inhibition of 50%
of the population is 30 𝜇M [8, 10] and in Caco-2 the IC
50
of
MA is 10.82 𝜇M [7], whereas in bladder cancer the IC
50
value
changed according to the bladder type cell lines, the values
being between 20 and 300 𝜇M [41].
3.2. Maslinic Acid Effect on Mitochondrial-Membrane Poten-
tial. DHR 123 is a ROS assay in which this compound can
be oxidized intracellularly by ROS to form the positively
charged fluorescent Rh123 [42] and is accumulated into the
mitochondria [43]. We have performed an assay of ROS
production by DHR in the absence of FBS and using three






) based on our
cytotoxicity results. Firstly, we have shown that the absence
of FBS produced an increase in ROS production due to mito-
chondrial disruption (Figure 3(a)). FBS composition includes
proteins, growth factors, hormones, and ions [44, 45]. Cell
culture without FBS forces the cell to synthesize all required
compounds necessary for its normal metabolic activity. This
fact involves an increase in the cellular metabolism which is
reflected in a higher cellularmitochondrial activity, indirectly
determined by DHR 123 assay as shown in quadrant 4 (Q4).
Our results indicated that ROS level decreased at lower
concentration of MA used (IC
50/8
). Increasing MA induced
a direct increase in ROS level; hence, a dose dependent





























































Figure 3: Positive fluorescent Rh123 on B16F10 cells with or without FBS (a) and after MA treatment at different dosages without FBS (b).
response was observed (Figure 3(b)). Among other proper-
ties, MA has been reported as a natural antioxidant [46–49].
In this context, the decrease in ROS level observed at MA
at IC
50/8
concentration could be attributed to its antioxidant
property. On the other hand, MA induces apoptosis by
activating intrinsic pathways that increase cellular ROS pro-
duction [4, 48–52].Mitochondria are the primary cellular site
of ROS production and, under certain conditions, elevated
mitochondrial ROS levels can serve as proapoptotic signals in
cancer cells; as a result, drugs that induce ROS are receiving
greater attention for their potential as chemotherapeutic
agents [53]. In our previous studies, we have shown that MA
induces apoptosis in cancer colon cells [10, 13, 54].
In the present study, the observed results on ROS pro-
duction at higher MA levels are not just probably due to the
absence of the antioxidant effect but due to a combination
of antioxidant and apoptotic properties of MA when cells
are cultured without FBS. Therefore, the increased MA levels
are related to the higher apoptotic capacity of triterpene as
shown by the higher ROS levels determined byDHR 123 assay
(Figure 3).
3.3. Antioxidant Enzymatic Response. An evaluation of the
activities of the antioxidant enzymes superoxide dismutase
(SOD), catalase (CAT), glucose 6-phosphate dehydrogenase
(G6PDH), and glutathione-S-transferase (GST) was per-
formed under our experimental conditions (Figure 4). The
results indicated that CAT, G6PDH, and SOD showed no
change in their activity in the absence of FBS compared to
the control with FBS, and only GST activity increased in the
absence of FBS with respect to control in the presence of
FBS, since this enzyme is related to detoxification of lipid
peroxidation products, which are being generated under the
assayed conditions.
WhenMA is added to the cell culture, CAT, G6PDH, and
GST activities decreased below controls data. This effect was
observed at all doses of MA used and in a dose dependent
response pattern. However, SOD activity in the presence
of MA was not affected. This variability in responses of
different antioxidant enzymes may be due to linked factor
combination. As previously indicated, MA induces apoptosis
at higher doses. Apoptosis mechanism involves biochemical
changes in the cells to achieve death. The changes observed
in the first step of apoptosis imply homeostatic cellular
disruption.
These alterations inhibit biosynthesis of new molecules
and damaged metabolites renewal, a fact related to the low
G6PDH activity observed. G6PDH is the main enzyme to
produceNADPHwhich is essential for reductive biosynthesis
and nucleic acid synthesis [55] and protects the cell against













































































































































































Figure 4: CAT (a), G6PDH (b), GST (c), and SOD (d) specific activities on B16F10 cells. On the left side, cells cultivated with and without
FBS, and on the right side, cell cultivated without FBS and differentMA dosages. Values are expressed asmeans ± SD. Different letters indicate
significant differences (𝑃 < 0.05).
oxidants [56]. Among other biological properties of NADPH,
it has been demonstrated that it protects CAT from inacti-
vation [57–59] and plays a crucial role in maintaining the
redox state of the cell through GSH regeneration fromGSSG.
Low NADPH levels due to the imbalance in the cellular
homeostasis could be, partially, responsible for the low
activity levels observed in CAT and GST enzyme activities.
All these results are in accordance with DHR 123 assay.
3.4. Validation by Western Blot. To corroborate the effect of
different MA levels in cells without FBS in the antioxidant
enzymes measured, an immune-blotting analysis was carried
out to confirm the differential expression of same specific
enzymes: CAT, G6PDH, GST, and SOD (Figure 5), under
the same experimental condition (MA levels without FBS).
Results obtained of immune-blotting analysis agree with
those in the enzyme analysis, tending to decrease their activ-
ity and expression as MA concentration increases without
FBS, although this pattern is not statistically significant in all
enzymes.
4. Conclusions
It has been described in the scientific literature that triter-
penes and polyphenols, in physiological doses, are able to
improve the intrinsic cell tolerance against oxidative stress by
increasing the antioxidant potential and modulation related
to proliferation/survival in cell cultures and experimenta-
tion animals. However, at supraphysiological doses, these
compounds appear to induce programmed death via the
activation of signals involved in apoptosis and inhibition of
proliferation proteins associatedwith survival/cell death.This
indicates that the experimental conditions (concentrations,
culture conditions, cell type, duration of the treatment, etc.)
have to be seriously considered as they may determine
the biological activity of these natural compounds. As it is
difficult to predict their effect, there is a need to understand
theirmolecularmechanisms of action in each context. Results
obtained in this paper must be considered in these experi-
mental conditions.
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Figure 5: Western blots of CAT (a), G6PDH (b), GST (c), and SOD (d) on B16F10 cells cultivated without FBS at different MA dosages. The
levels of specific protein expression are shown as arbitrary intensity units of each band compared to arbitrary intensity units of actin. Values
are expressed as means ± SD. Different letters indicate significant differences (𝑃 < 0.05).
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responsible for general coordination of writing. All authors
have read and approved the final version of the paper. Khalida
Mokhtari and Eva E. Rufino-Palomares have contributed
equally to this work.
Acknowledgments
This study has been supported, in part, by funds of the
consolidated Research Group BIO-157, from the General
Secretariat of Universities, Research and Technology of the
Ministry of Economy, Innovation, Science and Employment
Government of the Junta de Andalućıa (Spain), and by
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“(2𝛼,3𝛽)-2,3-Dihydroxyolean-12-en-28-oic acid, a new natural
triterpene fromOlea europea, induces caspase dependent apop-
tosis selectively in colon adenocarcinoma cells,” FEBS Letters,
vol. 580, no. 27, pp. 6302–6310, 2006.
[13] X. Wen, H. Sun, J. Liu et al., “Naturally occurring pentacyclic
triterpenes as inhibitors of glycogen phosphorylase: synthe-
sis, structure-activity relationships, and X-ray crystallographic
studies,” Journal ofMedicinal Chemistry, vol. 51, no. 12, pp. 3540–
3554, 2008.
[14] X. Wen, H. Sun, J. Liu et al., “Pentacyclic triterpenes. Part 1: the
first examples of naturally occurring pentacyclic triterpenes as a
new class of inhibitors of glycogen phosphorylases,” Bioorganic
& Medicinal Chemistry Letters, vol. 15, no. 22, pp. 4944–4948,
2005.
[15] X. Wen, P. Zhang, J. Liu et al., “Pentacyclic triterpenes. Part 2.
Synthesis and biological evaluation of maslinic acid derivatives
as glycogen phosphorylase inhibitors,” Bioorganic and Medici-
nal Chemistry Letters, vol. 16, no. 3, pp. 722–726, 2006.
[16] J. Liu, H. Sun, W. Duan, D. Mu, and L. Zhang, “Maslinic
acid reduces blood glucose in KK-Ay mice,” Biological &
Pharmaceutical Bulletin, vol. 30, no. 11, pp. 2075–2078, 2007.
[17] M. Fernández-Navarro, J. Peragón,V.Amores,M. de laHiguera,
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